Literature DB >> 21228887

Public perceptions of pandemic influenza resource allocation: a deliberative forum using Grid/Group analysis.

Stynke P Docter1, Jackie Street, Annette J Braunack-Mayer, Gert-Jan van der Wilt.   

Abstract

The emergence of virulent avian influenza A subtypes with potential to evolve into novel human subtypes prompted directives from the World Health Organisation recommending that countries prepare for a pandemic. In response the Australian government developed the Australian Health Management Plan for Pandemic Influenza (AHMPPI), which includes strategies to contain and/or manage a pandemic. To implement these strategies successfully, community compliance is necessary. Our qualitative study investigated, through a deliberative forum, the extent to which the antiviral drug and vaccine allocation of the AHMPPI corresponds with community views about the priority groups. We used Mary Douglas' Grid/Group analysis to analyse the results, which suggested that the AHMPPI's allocation strategy corresponds well with community views with both based on a hierarchical structure. There are some differences concerning community involvement in the decision process and information provision to the public, for which our study provides recommendations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228887     DOI: 10.1057/jphp.2010.49

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  2 in total

1.  The Fair Allocation of Scarce Medical Resources: A Comparative Study From Jordan.

Authors:  Muhannad H Yousef; Yazan N Alhalaseh; Razan Mansour; Hala Sultan; Naseem Alnadi; Ahmad Maswadeh; Yasmeen M Al-Sheble; Raghda Sinokrot; Khawlah Ammar; Asem Mansour; Maysa Al-Hussaini
Journal:  Front Med (Lausanne)       Date:  2021-01-12

2.  Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.

Authors:  C Degeling; J Williams; S M Carter; R Moss; P Massey; G L Gilbert; P Shih; A Braunack-Mayer; K Crooks; D Brown; J McVernon
Journal:  Vaccine       Date:  2020-12-13       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.